DTC Pre-Review Guidance In The Works For Rx TV Ads, FDA’s Abrams Says
Executive Summary
Certain drug classes will be required to submit certain types of ads, according to Tom Abrams, director of CDER’s recently elevated Office of Prescription Drug Promotion, but specifics will await the guidance itself.
You may also be interested in...
DTC Pre-Review Guidance Could Make Promotional Campaigns More Costly
PhRMA’s assistant general counsel says that FDA’s draft might increase expenses because of the need to submit final ads in advance and the potential to be asked for extensive revisions.
DTC Pre-review Requirement Broadly Defined Under FDA Draft Guidance
The agency’s draft guidance on prereview of television advertisements also requires companies to submit the information they rely on to support claims in an ad.
FDA’s Guidance Document To-Do List Grows
Since releasing its annual guidance agenda in December, FDA has added a number of guidances to its development agenda.